Vitamin K Dosing for Prolonged Prothrombin Time
For asymptomatic patients with elevated INR, administer 1–2 mg oral vitamin K when INR is 6–10, and 5 mg oral vitamin K when INR exceeds 10; for life-threatening bleeding, immediately give prothrombin complex concentrate (PCC) 25–50 IU/kg plus 10 mg intravenous vitamin K. 1
Clinical Context: Bleeding vs. Non-Bleeding
The management strategy hinges entirely on whether active bleeding is present and its severity:
Life-Threatening or Major Bleeding (INR > 1.5)
Immediate reversal is mandatory without waiting for laboratory confirmation:
- Administer PCC 25–50 IU/kg IV as the first-line agent; for intracranial hemorrhage specifically, use the higher dose of 50 IU/kg to achieve INR < 1.2. 1, 2
- Concurrently give vitamin K₁ 10 mg IV (or 100 µg/kg in children) by slow infusion over 30 minutes to sustain reversal beyond the 4-hour duration of PCC effect. 1, 2, 3
- PCC corrects INR within 3 minutes and is vastly superior to fresh frozen plasma, which requires large volumes (>30 mL/kg), acts more slowly, and carries transfusion-related risks including volume overload. 1, 2
- Check INR at 30 minutes post-reversal, then at 6–8 hours and 24 hours to detect rebound coagulopathy that may require additional PCC or vitamin K. 1, 2
Non-Severe Bleeding or Asymptomatic Elevated INR
Vitamin K alone suffices; PCC is not indicated:
| INR Range | Vitamin K Dose | Route |
|---|---|---|
| ≥ 4.0 to < 6.0 | 1–2.5 mg | Oral preferred [4,5] |
| 6.0–10.0 | 2 mg | Oral [2,4] |
| > 10.0 | 5 mg | Oral [2,4] |
- Oral administration is strongly preferred over subcutaneous (which is slow and unreliable) or intravenous (which carries a rare anaphylaxis risk of ~3 per 10,000 administrations). 1, 2, 4
- Oral vitamin K 1–2.5 mg reduces INR from 5.0–9.0 to 2.0–5.0 within 24–48 hours. 4
- A single 1 mg oral dose reliably lowers INR from a mean of 5.79 to 2.86 within 16 hours in asymptomatic patients. 5
- Intravenous vitamin K acts faster than oral (INR correction within 24 hours vs. 24–48 hours) but should be reserved for situations where oral intake is not feasible. 1, 4
Dosing Nuances and Evidence Strength
Tailored dosing may outperform fixed dosing in specific contexts:
- A 2017 randomized trial demonstrated that individualized vitamin K dosing based on index INR and body surface area returned 68.9% of patients to target INR within 24 hours, compared to only 52.8% with fixed 1–2 mg doses (P = 0.026). 6
- However, for practical bedside use, the fixed-dose regimens outlined above remain guideline-endorsed and simpler to implement. 1, 2, 4
Lower doses (0.5–1 mg IV) may be optimal for moderate over-anticoagulation:
- A 2000 randomized study found that 0.5 mg IV vitamin K achieved optimal response (INR 2–4 at day 1) in 67% of patients with INR 7–9.5, whereas 1–2 mg doses overcorrected the majority to INR < 2.0. 7
- This suggests that for INR 7–9.5 without bleeding, 0.5–1 mg IV vitamin K is sufficient if the intravenous route is chosen. 7
Pre-Operative Management
For elective surgery when INR is mildly elevated (1.1–1.5):
- An INR ≤ 1.2 is acceptable even for high-risk neurosurgical and neuraxial procedures; therefore an INR of 1.13–1.5 does not require vitamin K for most operations. 1, 8
- The 2022 American College of Chest Physicians guideline recommends against routine pre-operative vitamin K when INR is 1.5–2.0 measured 1–2 days before surgery, citing concerns about resistance to post-operative re-anticoagulation and lack of robust efficacy data. 9
- If vitamin K is given pre-operatively for INR 1.4–1.9, a 1 mg oral dose normalized INR (≤ 1.3) in 76.6% of patients by the day of surgery. 9
Common Pitfalls to Avoid
- Do not use subcutaneous vitamin K; it provides the slowest and least reliable correction compared to oral or IV routes. 1, 2
- Do not administer fresh frozen plasma as first-line reversal for urgent bleeding; PCC is faster, more effective, and safer. 1, 2
- Do not give vitamin K prophylactically before coagulopathy is documented; this delays necessary procedures without proven benefit. 8, 2
- Do not assume a 10 mg dose is always better; while 10 mg achieves faster INR reduction than 5 mg, it prolongs the time to re-achieve therapeutic INR when warfarin is resumed post-operatively. 1
- Do not stop monitoring after initial INR correction; INR rebound occurs and is associated with recurrent bleeding risk, necessitating serial checks at 6–8 hours and 24 hours. 1, 2
Route-Specific Considerations
Intravenous vitamin K:
- Infuse slowly at no more than 1 mg per minute to minimize anaphylaxis risk. 3
- May be diluted in preservative-free 0.9% sodium chloride, 5% dextrose, or 5% dextrose with sodium chloride; benzyl alcohol preservatives are contraindicated in newborns. 3
- Provides faster correction than oral dosing but carries a small anaphylaxis risk; reserve for patients unable to take oral medication or when rapid correction (within 6–12 hours) is essential. 1, 4
Oral vitamin K: